Mode
Text Size
Log in / Sign up

Falciparum Malaria

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Falciparum Malaria

26 trials tracked for Falciparum Malaria: 6 in phase 3 or 4 and 5 with published results. The most-cited published study has 246 citations.

26Trials tracked
6Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 4 1 Phase 3 5 Phase 2 9 Phase 1 9 Other / NA 2
  1. Phase 3 Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Completed · 246 cited
  2. Phase 3 Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients Completed · 112 cited
  3. Phase 3 Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam Completed · 81 cited
  4. Phase 3 Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study Completed · 71 cited
  5. Phase 4 Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE) Completed · 8 cited
  6. Phase 3 Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa Completed
Show 20 more trials
  1. Phase 2 Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine Completed
  2. Phase 2 PfSPZ Vaccine Trial in Malian Children Completed
  3. Phase 2 Methylene Blue Against Falciparum Malaria in Burkina Faso Completed
  4. Phase 2 Safety and Protective Efficacy of Pb(PfCS@UIS4) Completed
  5. Phase 2 Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria Completed
  6. Phase 2 Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection Completed
  7. Phase 2 Efficacy of ArTiMist™ in Children Completed
  8. Phase 2 Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults Completed
  9. Phase 2 A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria Completed
  10. Phase 1 Safety and Efficacy of R0.6C Vaccine Completed
  11. Phase 1 Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum Completed
  12. Phase 1 Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites Completed
  13. Phase 1 Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali Completed
  14. Phase 1 First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367 Completed
  15. Phase 1 Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F Completed
  16. Phase 1 Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54 Completed
  17. Phase 1 A Study to Investigate the Safety, Tolerability and Pharmacokinetics of OZ439 in Healthy Male and Female Subjects Completed
  18. Phase 1 Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria Completed
  19. N/A TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014 Completed
  20. N/A Controlled Human Malaria Infection Model for Evaluation of Transmission-blocking Interventions - Study 2 Completed

Showing the 26 most-cited and recently-updated of 26 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.